Diagnostic journeys in myeloma – understanding barriers and facilitators

Matthew LeBlanc
Published:
Sign up to join the conversation
Members only

While these data highlight the problem, they don’t explain the underlying causes. We wanted to capture the real-world experiences, decisions, and contexts that shape people’s routes to diagnosis. Through these interviews, we heard how people’s journeys often began with new or stubborn symptoms, critical medical events such as kidney failure or fractures, or the discovery of abnormal test results.

Sign up and become a member of the Myeloma UK HCP Hub

Access exclusive content like this and join in the conversation.

Already have an account?